Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies
Running, not enrolling · Phase 3
Conditions studied: B-cell Malignancies
In brief
The purpose of this study is to evaluate the long-term safety of zanubrutinib regimens in participants with B-cell malignancies who participated in a BeiGene parent study for zanubrutinib.
Key facts
- Study ID
- NCT04170283
- Run by
- BeiGene
- People needed
- 955
- Starts
- 2020-01-16
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2025-10-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Carti Cancer Center — Little Rock, Arkansas, United States
- Rocky Mountain Cancer Centers Centennial — Centennial, Colorado, United States
- Colorado Blood Cancer Institute — Denver, Colorado, United States
- Florida Cancer Specialists Fort Myers — Fort Myers, Florida, United States
- Scri Florida Cancer Specialists North — St. Petersburg, Florida, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- University of Michigan Health System — Ann Arbor, Michigan, United States
- Mayo Clinic Rochester — Rochester, Minnesota, United States
- Forrest General Hospital Cancer Center — Hattiesburg, Mississippi, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
- Summit Medical Group — Florham Park, New Jersey, United States
- Atlantic Health System — Morristown, New Jersey, United States
- Clinical Research Alliance, Inc — Westbury, New York, United States
- Duke University Hospital — Durham, North Carolina, United States
- Oncology Associates of Oregon Willamette Valley Cancer Center — Eugene, Oregon, United States
- Oregon Health and Science University — Portland, Oregon, United States
- Scri Tennessee Oncology Chattanooga — Chattanooga, Tennessee, United States
- Tennessee Oncology — Nashville, Tennessee, United States
- Texas Oncology Fort Worth Cancer Center — Fort Worth, Texas, United States
- The University of Texas Md Anderson Cancer Center — Houston, Texas, United States
- Texas Oncology San Antonio Medical Center Usor — San Antonio, Texas, United States
- Oncology and Hematology Associates of Southwest Virginia, Inc — Roanoke, Virginia, United States
- University of Washington Seattle Cancer Alliance — Seattle, Washington, United States
- Banner Md Anderson Cancer Center — Gilbert, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.